• Future Market Insights recently reported that the global plant-based protein market has entered a high-growth phase, with demand accelerating for functional, application-ready protein systems across beverages, bakery, ready-to-eat foods, and nutrition products.
• This shift from standalone protein ingredients to integrated solutions that combine taste, texture, and nutrition could benefit suppliers like Ingredion that focus on value-added, performance-driven protein systems.
• We will now examine how this growing demand for integrated, application-ready plant-based proteins may influence Ingredion's existing investment narrative.

The latest GPUs need a type of rare earth metal called Terbium and there are only 31 companies in the world exploring or producing it. Find the list for free.

Ingredion Investment Narrative Recap

To own Ingredion, you need to believe it can keep shifting its mix toward higher value specialty ingredients while managing pressure in legacy starches and sweeteners. The new research on high growth, application ready plant proteins reinforces the importance of Ingredion’s protein portfolio, but does not appear to change the near term focus on defending margins against price and mix headwinds or the key risk from weaker volumes and currency volatility in Latin America.

The recent global R&D collaboration with Shiru on AI driven discovery of functional proteins and prebiotics looks particularly relevant here, because it ties directly to the move toward integrated, performance focused protein systems. For investors watching Ingredion’s catalysts, this kind of partnership sits squarely in the innovation and specialty growth bucket that management has highlighted as critical for offsetting softness in more mature product lines.

Yet even as interest in plant based proteins grows, investors should also be aware of how ongoing pressure in legacy starches and HFCS could...

Ingredion's narrative projects $7.8 billion revenue and $791.0 million earnings by 2029. This requires 2.4% yearly revenue growth and a $62.0 million earnings increase from $729.0 million today.

Uncover how Ingredion's forecasts yield a $127.14 fair value, a 11% upside to its current price.

Exploring Other Perspectives

Three Simply Wall St Community fair value estimates for Ingredion span roughly US$127 to US$185 per share, showing how far opinions can stretch. Against this, the key risk remains that persistent weakness in legacy starches and HFCS could limit how much the growing specialty and plant based portfolio contributes to overall performance, so it is worth weighing several viewpoints before deciding how this fits in your portfolio.

Explore 3 other fair value estimates on Ingredion - why the stock might be worth as much as 62% more than the current price!

The Verdict Is Yours

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Ingredion research is our analysis highlighting 4 key rewards that could impact your investment decision.
• Our free Ingredion research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Ingredion's overall financial health at a glance.

Interested In Other Possibilities?

Right now could be the best entry point. These picks are fresh from our daily scans. Don't delay:

• The future of work is here. Discover the 34 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.
• Capitalize on the AI infrastructure supercycle with our selection of the 39 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
• We've uncovered the 13 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.